Caught in the middle: How health insurance companies influence cancer drug selection

Patients may find themselves caught in the middle between their health insurance company and their oncologist when it comes to selecting the drugs used to treat their cancer. Why is this?

The American Cancer Society explains biologic drugs (derived from living organisms such as yeast, bacteria, or animal cells) and biosimilar drugs, which behave similarly to the original, patented (i.e., brand) drug. It is important to note that biosimilar drugs are not the same as generic drugs, which are exact chemical copies of the original, brand drug.

Click here to read the full article